Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection Journal Article


Authors: Lacerda, J. F.; Göker, E.; Kheradpour, A.; Dennig, D.; Elisseyeff, Y.; Jagiello, C.; O'Reilly, R. J.; Bertino, J. R.
Article Title: Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection
Abstract: Impaired transport of methotrexate (MTX) is a common resistance mechanism of tumor cells to this drug. Trimetrexate (TMTX), a second-generation folate antagonist, is still active against MTX-transport-resistant cells because it enters cells by passive diffusion and does not use the reduced folate transport system for cell entry. Therefore, although leucovorin (LV) protects MTX-sensitive cells from TMTX toxicity, MTX-transport defective cells are poorly rescued by LV. Severe combined immunodeficiency mice bearing MTX- transport-resistant CCRF-CEM acute lymphoblastic leukemia tumors were treated with TMTX alone or with the combination of TMTX and LV, with tumor regressions in both groups (P < .001) and without significant toxicity. These results indicate that TMTX with LV protection may be a useful therapeutic regimen for patients with MTX-transport-defective acute lymphoblastic leukemia. Furthermore, resistance to TMTX plus LV may result in reversion to MTX sensitivity.
Keywords: human cell; nonhuman; methotrexate; animal cell; mouse; animal; mice; antineoplastic combined chemotherapy protocols; cytotoxicity; drug effect; drug resistance; mice, scid; acute lymphoblastic leukemia; folinic acid; leukemia cell; transplantation, heterologous; neoplasm transplantation; tumor growth; leucovorin; combined immunodeficiency; biological transport; tumor resistance; cell membrane transport; trimetrexate; protection; leukemia, lymphocytic, acute; active transport; human; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
Journal Title: Blood
Volume: 85
Issue: 10
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1995-05-15
Start Page: 2675
End Page: 2679
Language: English
PUBMED: 7742525
PROVIDER: scopus
DOI: 10.1182/blood.V85.10.2675.bloodjournal85102675
DOI/URL:
Notes: Article -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joseph Bertino
    363 Bertino
  2. Richard O'Reilly
    747 O'Reilly
  3. Erdem Göker
    24 Goker
  4. Dieter Dennig
    22 Dennig